Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
55 /100
HIGH RISK
Score updated Oct 27, 2026

IMDX — Insight Molecular Diagnostics Inc. Dilution Risk Tracker

Track IMDX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IMDX — Get alerts when the score changes →

As of October 27, 2026, Insight Molecular Diagnostics Inc. (IMDX) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. Insight Molecular Diagnostics Inc. has a market capitalization of $98.01M, 32.72M shares outstanding, 43 institutional holders tracked. Stored dilution-related fields include 573.2K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔔 Track IMDX — Get forecast alerts →

Market Data

Market Cap$98.01M
Shares Outstanding32.72M
Float10.08M
Cash$17.76M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore55/100DilutionWatch score record
Shares Outstanding32.72MVerified float table or market cache
Public Float10.08MVerified float table or market cache
Market Cap$98.01MMarket data cache
Cash Runway8.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants573.2KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

IMDX SEC Filing Activity — Last 12 Months

Shares outstanding reported by IMDX on the cover page of its latest 10-K/10-Q: 32.72M as of August 03, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for IMDX in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)3Aug 10, 2026
10-Kannual report1Mar 26, 2026
10-Qquarterly report1May 13, 2026
3initial insider ownership14Jul 24, 2026

Institutional Holdings

QoQ: ↑ 17.4% shares (2026Q1 vs prior)
43 institutional holders · 19.61M shares
#1 BROADWOOD CAPITAL INC 11.93M shares
#2 AWM Investment Company, Inc. 2.81M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.07M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest949.5K
Days to Cover3.2
% of Float9.4%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-10
xbrl XBRL CONVERTIBLE 2018-04-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual IMDX Dilution Snapshot

Insight Molecular Diagnostics Inc. (IMDX) has a DilutionScore of 55/100, rated High dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

IMDX's DilutionScore is currently 55/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 52/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 27, 202655/100HIGH67 days
Aug 14 – Aug 21, 202652/100HIGH7 days
Jul 30 – Aug 13, 202647/100MEDIUM15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

IMDX shares outstanding have increased 0.4% from 32.17M (Mar 2026) to 32.29M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 202632.29M10.08M▲ 1.20%
May 01, 202632.17M9.96M▼ 7.03%
Apr 03, 202632.17M10.72M▼ 0.52%
Mar 30, 202632.17M10.77M▲ 12.22%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track IMDX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment IMDX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking IMDX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Med Devices sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IMDX
IMDX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.